TLIS logo

Talis Biomedical (TLIS)

Profile

Full Name

Talis Biomedical Corporation

Ticker Symbol

TLIS

Exchange

NASDAQ

Country

United States

IPO

February 12, 2021

Indexes

Not included

Employees

99

Key Details

Price

$1.70(0.00%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$412.00K(-88.72% YoY)

Annual EPS

-$34.12(+45.64% YoY)

PE ratio

-

Next earnings date

May 8, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price Performance

Price Range

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Shares Outstanding

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

EPS

Profit

Expenses

EBIT & EBITDA

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Liabilities

Debt

Equity & Capital

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

CAPEX

Free Cash Flow

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

ROA & ROE

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Analyst ratings

Recent major analysts updates

Aug 16, 23 BTIG
Sell
Mar 18, 22 BTIG
Sell
Mar 16, 22 B of A Securities
Underperform
Jan 7, 22 B of A Securities
Underperform
Sep 27, 21 JP Morgan
Underweight
Aug 12, 21 Piper Sandler
Neutral
Aug 11, 21 JP Morgan
Neutral
Mar 9, 21 Piper Sandler
Overweight
Mar 9, 21 JP Morgan
Overweight
Mar 9, 21 BTIG
Buy

Institutional Ownership

  • What is the ticker symbol for Talis Biomedical?
  • Does Talis Biomedical pay dividends?
  • What sector is Talis Biomedical in?
  • What industry is Talis Biomedical in?
  • What country is Talis Biomedical based in?
  • When did Talis Biomedical go public?
  • Is Talis Biomedical in the S&P 500?
  • Is Talis Biomedical in the NASDAQ 100?
  • Is Talis Biomedical in the Dow Jones?
  • When was Talis Biomedical's last earnings report?
  • When does Talis Biomedical report earnings?
  • Should I buy Talis Biomedical stock now?

What is the ticker symbol for Talis Biomedical?

The ticker symbol for Talis Biomedical is NASDAQ:TLIS

Does Talis Biomedical pay dividends?

No, Talis Biomedical does not pay dividends

What sector is Talis Biomedical in?

Talis Biomedical is in the Healthcare sector

What industry is Talis Biomedical in?

Talis Biomedical is in the Medical Devices industry

What country is Talis Biomedical based in?

Talis Biomedical is headquartered in United States

When did Talis Biomedical go public?

Talis Biomedical's initial public offering (IPO) was on February 12, 2021

Is Talis Biomedical in the S&P 500?

No, Talis Biomedical is not included in the S&P 500 index

Is Talis Biomedical in the NASDAQ 100?

No, Talis Biomedical is not included in the NASDAQ 100 index

Is Talis Biomedical in the Dow Jones?

No, Talis Biomedical is not included in the Dow Jones index

When was Talis Biomedical's last earnings report?

Talis Biomedical's most recent earnings report was on Aug 10, 2024

When does Talis Biomedical report earnings?

The next expected earnings date for Talis Biomedical is May 8, 2025

Should I buy Talis Biomedical stock now?

As of today, analysts generally recommend a 'Strong sell' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page